RENAL CARCINOMA
Clinical trials for RENAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RENAL CARCINOMA trials appear
Sign up with your email to follow new studies for RENAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney cancer: targeted pill aims to stop tumor growth
Disease control Recruiting nowThis study tests a daily pill called olaparib in 20 adults with advanced kidney cancer that has spread. To join, your cancer must have a specific gene change (like BAP-1 or BRCA) and you must have already tried at least one other treatment. The goal is to see if olaparib can shri…
Matched conditions: RENAL CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug combo aims to shrink kidney tumors before surgery
Disease control Recruiting nowThis phase 2 trial is testing whether the drug casdatifan, alone or with zimberelimab, can safely shrink kidney tumors before surgery in people with clear cell renal cell carcinoma. About 32 adults with advanced or high-risk kidney cancer will receive the drugs before their plann…
Matched conditions: RENAL CARCINOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Cheaper pain cocktail may rival exparel in kidney surgery trial
Symptom relief Recruiting nowThis phase 3 trial tests whether a combination of four drugs (R.E.C.K) controls pain after robotic kidney surgery as well as the more expensive drug Exparel. About 170 adults having robotic partial or total kidney removal will be randomly assigned to receive one of the two inject…
Matched conditions: RENAL CARCINOMA
Phase: PHASE3 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC